European Commission approves Novartis' lung cancer drug Zykadia

… (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib … B (also known as ASCEND-2). Lung Cancer Europe (LuCE) board member Stefania … testing for genetic drivers in lung cancer plays a critical role as … brings new hope to the lung cancer community as we continue to …